The outcome of IHE initiatives is providing better information for developing health policy and best medical practices. IHE disseminates information in many ways. In addition to publications in peer-reviewed journals, IHE produces books and a variety of reports synthesizing information in a particular field.
If you cannot find the publication or report you are seeking, please contact us at [email protected]. Thank you!
Refine your search by clicking filters to the left.
“The IHE is delighted to welcome Rob Seidel as Board Chair,” said Dr. McCabe, the IHE’s CEO and Executive Director. “Rob Seidel’s extensive experience in board governance and in leading health-related organizations such as Alberta Innovates – Health Solutions has clearly demonstrated his significant expertise and commitment to developing successful partnerships and collaborations…
The specific policy outlined in this document relates directly to Board members of the Institute of Health Economics in performing their governance role.
This Privacy Statement of the Institute of Health Economics (IHE), 1200 – 10405 Jasper Avenue NW, Edmonton, Alberta T5J 3N4 ("IHE" "we" "us" or "our") outlines how your personally identifiable information and other data relating to you (your "personal data") will be collected, used, and shared in connection with your access to and/or use of IHE.ca, and affiliated sites NOAHE.ca…
The IHE Policy Surrounding Political Activity outlines the expectation of the Institute of Health Economics (IHE) for staff surrounding political activity.
The Institute of Health Economics (IHE) and Applied Pharmaceutical Innovation (API) are creating value through collaboration. The IHE and API have signed a Memorandum of Understanding (MOU) in the field of economic analysis and health technology assessment to support each other’s aspiration in the development of a broader, stronger, and more vibrant innovation ecosystem. “Successful…
| Dat Tran, Ilke Akpinar, Irvin Mayers, Tatiana Makhinova, Philip Jacobs
The objective of this study, published in the International Journal of Chronic Obstructive Pulmonary Disease, was to describe the trends in pharmacologic treatment for patients newly diagnosed with chronic obstructive pulmonary disease (COPD) in Alberta, Canada.
L'IHE, le Centre de recherche de l'Institut universitaire en santé mentale de Montréal et l'Université de Montréal ont le plaisir d'annoncer la publication de IHE SÉSaMe 2019 – un manuel virtuel de statistiques économiques sur la santé mentale qui résume les données les plus récentes disponibles concernant les indicateurs ayant une incidence sur les divers aspects économiques du…
The IHE, the Centre de recherche de l’Institut universitaire en santé mentale de Montréal, and the Université de Montréal are pleased to announce the release of IHE Mental Health In Your Pocket 2019 – a virtual handbook of mental health economic statistics that synthesizes the most current, available data on indicators that affect the various economic aspects of the Canadian mental…
IHE Mental Health In Your Pocket 2019 is a pan-Canadian virtual handbook of mental health economic statistics, developed in partnership with the Centre de recherche de l’Institut universitaire en santé mentale de Montréal and Montréal University, which synthesizes a large amount of the most currently available data into indicators on the various economic aspects of the mental health…
IHE SÉSaMe 2019 est un recueil virtuel pancanadien de statistiques économiques sur la santé mentale, élaboré en partenariat avec le Centre de recherche de l'Institut universitaire en santé mentale de Montréal et l'Université de Montréal, qui synthétise une grande partie des données actuellement disponibles en indicateurs sur les divers aspects économiques du système de santé mentale.…
L’IHE dans votre poche 2017 – Guide de statistiques sur l’économie de la santé September 19, 2017 L’IHE dans votre poche 2017 – Guide de statistiques sur l’économie de la santé présente et divise les données les plus récentes en sections portant sur le fardeau économique de la maladie, les ressources en soins de santé, les comportements liés à la santé, l'état de santé, les données…
IHE Mental Health In Your Pocket 2019 is a compendium of economic statistics about mental health in Canada; it brings together information that demonstrates the burden of mental illness and where Canada’s mental health system ranks among other developed countries. To provide important consolidated information on key indicators that depict the state of our mental health system,…
IHE Statistiques économiques en santé mentale dans votre poche (SÉSaMe) 2019 est un recueil de statistiques économiques sur la santé mentale au Canada. Il rassemble des informations qui démontrent le fardeau que représentent les maladies mentales et indiquent la position relative du système de santé mentale canadien…
08:00 – 08:15 Opening Remarks John Sproule, Senior Policy Director, IHE 08:15 – 09:15 Implementation science: If it's not knowledge translation, and not change management, what is it?Dr. Carl May, Professor, Medical Sociology, London School of Hygiene & Tropical Medicine Download Presentationhttps://vimeo.com/357889527 09:15 – 09:30 Audience Questions 09:25 – 09:30 Closing Remarks…
PDF of a PowerPoint presentation by Dr. Carl May, Professor of Medical Sociology at the London School of Hygiene and Tropical Medicine.
Implementation Science Breakfast Plenary
The IHE is pleased to have partnered with Abbott and other global health industry leaders to launch the UNIVANTS of Healthcare Excellence award. This annual award honours integrated, multidisciplinary clinical care teams with innovative approaches to achieve measurably better healthcare performance for patients, clinicians, payers, and healthcare institutions. The UNIVANTS of Healthcare…
The IHE was founded on the belief that the best solutions to healthcare problems will be found through collaboration, with all stakeholders at the table sharing expertise, insights, and experiences. The Institute is committed to acting as critical friend, trusted partner, and neutral broker to engage the public, private, and academic sectors to help solve some of the complex challenges…
| Charles Yan, Katherine Rittenbach, Sepideh Souri, Peter H. Silverstone
This analysis, published in BMC Psychiatry, aimed to determine cost-effectiveness of a stepped-care pathway for depression in adults in primary care versus standard care (SC), treatment-as-usual (TAU), and online cognitive behavioural therapy (CBT).
| Samuel N. Frempong, Andrew J. Sutton, Clare Davenport, Pelham Barton
The aim of this study, published in PharmacoEconomics – Open, was to conduct an early economic analysis of a hypothetical rapid test for typhoid fever diagnosis in Ghana and identify the necessary characteristics of the test for it to be cost effective in Ghana.
The IHE is delighted to have provided support to CASA for the very popular and well-attended Dr. Roger Bland Community Lecture Series. This mini-series addressed important issues in children’s mental health, with each event featuring a keynote speaker and an expert panel to lead the conversation and answer audience questions. Each of these free events welcomed everyone to attend…
This study, published in PharmacoEconomics – Open, reports exploratory analysis of the provincial and nationwide costs of industry-sponsored drug clinical trials (CTs) in Canada. The costs of industry-sponsored drug CTs completed in 2016 were Can$2.1 billion. In addition to the creation of knowledge, these trials play an important role in alleviating the healthcare cost burden…
| Dat Tran, Thanh Nguyen, Arto Ohinmaa, Irvin Mayers, Philip Jacobs
OBJECTIVES: To examine the resource use and healthcare costs for chronic obstructive pulmonary disease (COPD) in Alberta, Canada between 2008 and 2016 and model the future costs to 2030.
Clinical research is funded by industry, governments, charities, and hospitals. It is important to know the economic commitment of the various funding bodies, but until now there has been no national source available which provides these data. We surveyed the major funders to provide such a measure. There is evidence that government and charity funding of medical research is a…
The IHE can provide health economics-related insights and research to support the decision-making of any and all health system stakeholder groups. For more information, please contact us at (780) 448 4881, or by email at [email protected]. Examples of Past Collaborations Metabolomic Technologies Inc. Alberta to begin assessing a new colorectal cancer screening strategy using Metabolomic…
Economic analysis, especially in reflection of the current funding climate, has become a critical way to describe the cost-effectiveness, cost-benefit, and/or cost-efficiency of new innovations, and contributes to the value propositions for real-world application. Including an applied health economics research component in grant applications can increase your likelihood of grant…
Be Confident in Your Decisions Changing how Alberta pays for health care is critical to improve value, achieve better quality, and slow cost growth. There is a need in Alberta for greater capacity in applied economics knowledge that both enhances economic surveillance that is independent from government, and supports ongoing provincial development of organizational and incentive…
In this photo (from left): Dr. Arto Ohinmaa (University of Alberta), Dr. Mike Paulden (University of Alberta), Ryan Au (Award Winner), Ryan Fung (Award Winner), Julia Dabravolskaj (Award Winner), Carla Ickert (Award Winner), Dr. Christopher McCabe (IHE) The IHE is delighted to congratulate Ryan Au, Julia Dabravolskaj, Ryan Fung, and Carla Ickert of the University of Alberta as…
In this photo (from left): Dr. Mingshan Lu (University of Calgary), Dr. Christopher McCabe (IHE), Eashita Dabas (Award Winner), Kolawole Adedapo (Award Winner), Melanie Varkey (Award Winner), Dr. Jeff Round (IHE). Missing (inset): Anuj Sharma (Award Winner) The IHE is delighted to congratulate Kolawole Adedapo, Eashita Dabas, Anuj Sharma, and Melanie Varkey of the University of…
| Helena M Earl, Louise Hiller, Anne-Laure Vallier, Shrushma Loi, Karen McAdam, Luke Hughes-Davies, Adrian N Harnett, Mei-Lin Ah-See, Richard Simcock, Daniel Rea, Sanjay Raj, Pamela Woodings, Mark Harries, Donna Howe, Kerry Raynes, Helen B Higgins, Maggie Wilcox, Chris Plummer, Janine Mansi, Ioannis Gounaris, Betania Mahler–Araujo, Elena Provenzano, Anita Chhabra, Jean E Abraham, Carlos Caldas, Peter S Hall, Christopher McCabe, Claire Hulme, David Miles, Andrew M Wardley, David A Cameron
Adjuvant trastuzumab significantly improves outcomes for patients with HER2-positive early breast cancer. The standard treatment duration is 12 months but shorter treatment could provide similar efficacy while reducing toxicities and cost. We aimed to investigate whether 6-month adjuvant trastuzumab treatment is non-inferior to the standard 12-month treatment regarding disease-free…
| Michelle Pollock, Ann Scott, Jennifer Seida, Paula Corabian, Andrew J. Sutton, Mike Paulden, Christopher McCabe, Lisa Tjosvold, Bing Guo
The clinical review and economic evaluation aimed to determine how Oncotype DX and Prosigna can be optimally used to determine which patients with early-stage breast cancer will benefit from adjuvant chemotherapy. This report addresses the following research question: For patients with early-stage (I–III), ER+, HER2?, node-negative or node-positive (one to three nodes) breast…
12:20 – 12:30 Opening RemarksKen Bond, Director of HTA and External Relationships, IHE 12:30 – 13:15 Big questions about big data: Social and ethical implications of using real-world data in the public and private sectorsProf Annette Braunack-Mayer, Head, School of Health and Society, University of Wollongong, AustraliaDownload Presentation 13:15 – 13:25 Audience Questions 13:25…
Biographies Prof Annette Braunack-Mayer Prof Braunack-Mayer is a bioethicist and public health researcher. Her research combines ethical analysis with a wide range of qualitative methods for engaging with citizens, patients, consumers and stakeholders. She has particular expertise in the use of deliberative methods of engagement with communities, but her research skill set extends…
29 May 2019 Edmonton, Alberta On May 29, 2019, the Institute of Health Economics (IHE), the Network of Alberta Health Economists (NOAHE) and the Alberta Real World Evidence Consortium (Alberta RWE) were delighted to host Prof Annette Braunack-Mayer of the University of Wollongong, Australia, who discussed the social and ethical issues related to the collection and use of real world…
PDF of a PowerPoint presentation by Prof Braunack-Mayer, Head, School of Health and Society, University of Wollongong, Australia.
Big Questions about Big Data Event
| Timothy Caulfield, Alessandro R Marcon, Blake Murdoch, Jasmine Brown, Sarah Tinker Perrault, Jonathan Jarry, Jeremy Snyder, Samantha J Anthony, Stephanie Brooks, Zubin Master, Christen Rachul, Ubaka Ogbogu, Joshua Greenberg, Amy Zarzeczny, Robyn Hyde-Lay
Abstract: Numerous social, economic and academic pressures can have a negative impact on representations of biomedical research. We review several of the forces playing an increasingly pernicious role in how health and science information is interpreted, shared and used, drawing discussions towards the role of narrative. In turn, we explore how aspects of narrative are used in…
Due to positive response to the IHE’s Health Economics Educational Workshop held in Calgary and Edmonton in November 2018, the IHE is now offering an online edition – the IHE Health Economics Virtual Workshop. The IHE Health Economics Virtual Workshop is a free, online workshop for small- and medium-sized life science companies. This online course is designed to help participants…
Learn how health economics and early-stage technology assessment can support your research and development planning, raise capital, and help communicate your value proposition more clearly and effectively to payers. The IHE provides Alberta small- and medium-sized enterprises (SMEs) and innovation ecosystem partners with educational services to describe the importance of, and requirements…
Be confident in your investment decisions - evaluate the commercial potential of healthcare technology in development through the IHE Early-Stage Life Sciences Technology Assessment service. The IHE provides services for early-stage small- and medium-sized enterprise (SME) technology developers (or other innovators, such as an academic group considering forming an SME) to present…
What are the prerequisites? Although this course was developed for a life science audience, it is open to anyone interested. There are no prerequisites required to take this course. Who is providing this course? The Institute of Health Economics developed this course and its content material. Who teaches the content? The course is taught by Health Economists from the Institute…
The IHE’s Small- and Medium-Sized Enterprise (SME) Commercialization Platform is pleased to present the IHE Health Economics Virtual Workshop – a free, online course where you can learn more about how health economics and early-stage technology assessment can support research and development planning, support with raising capital, and help communicate technology value proposition…
| Dat Tran, Thanh Nguyen, Dawn Opgenorth, Xiaoming Wang, Danny Zuege, David A. Zygun, Henry T. Stelfox, Sean M. Bagshaw
This study, published in the Journal of Critical Care, explores the association between strained ICU capacity and healthcare costs, and demonstrates the admissions to ICUs experiencing strain incur incremental costs, attributed to longer hospitalization and physician services.
| Paula Corabian, Bing Guo, Carmen Moga, Ann Scott
This article retrospectively examines the evolution of rapid assessments (RAs) produced by the Health Technology Assessment (HTA) Program at the Institute of Health Economics over its 25-year relationship with a single requester, the Alberta Health Ministry (AHM).
| Paula Corabian, Bing Guo, Carmen Moga, Ann Scott
The Health Technology Assessment Program at the Institute of Health Economics has conducted rapid assessments (RAs) since 1993. This information paper draws on this experience and describes the evolution of RA process and products over a 25-year relationship with a single requester to quantify the effects of this partnership on the RAs produced. The aim is to contribute to emergent…
| Nancy Zuck, John Sproule, Charles Cook, Rebecca Albrecht
Alberta Health initiated the Nurse Practitioner Demonstration Project(s) (NPDP) in 2016 to support access to and further integration of Nurse Practitioners (NPs) into Alberta’s primary health care system. Funding was provided (based on diverse program plans) to the Boyle McCauley Health Centre (BMHC), The Alex Community Health Centre (The Alex), the Calgary Urban Project…
Ce rapport fournit un résumé d’un atelier de sprint sur la conception de données probantes du monde réel (DPMR) qui a eu lieu le 21 octobre 2018 à Toronto, en Ontario. L’atelier a été conçu et offert dans le cadre d’un partenariat entre l’Agence canadienne des médicaments et des technologies…
Abstract: The cost of drug development is commonly cited between US$800 and US$1.8 billion. A similar statistic for vaccines is yet to be estimated, and it is unclear whether the cost of vaccines is similar to drug development. Financial and regulatory policy significantly impacts the extent and cost of pharmaceutical development, and as such it is important that…
| Thanh Nguyen, Anderson Chuck, Arto Ohinmaa, Philip Jacobs
Objectives: To estimate the monetary benefits of ramipril and its distribution over time among four beneficiaries in Canada: the drug developing manufacturer, generic manufacturers, the healthcare sector and employment sectors.
Speaker Biographies Keynote Speaker Louis Hugo Francescutti, MD, PhD, MPH, FRCPC, FACPM, CCFP, FRCP(Ire), FRCP(Edin), ICD-D, CCPEPresident, Canadian Medical Association, 2013-14 Dr. Louis Francescutti received his combined Doctor of Philosophy (Immunology) in 1985 and Doctor of Medicine in 1987 from the University of Alberta. In 1994, he completed further studies in injury control…
28 November 2013Edmonton, Alberta Welcome and Greetings from the Minister of Health Honourable Fred Horne, Minister of Healthhttp://vimeo.com/channels/907291/81424176 Keynote presentation Let's Talk Health and Not HealthcareDr. Louis Hugo Francescutti, President, Canadian Medical AssociationDownload Presentation http://vimeo.com/channels/907291/81416417 Disclaimer:…
28 November 2013 Edmonton, Alberta Choosing Wisely® in Health Care: A Canadian Perspective is the tenth IHE Innovation Forum, a semi-annual event bringing together senior public- and private-sector decision-makers to address policy issues of importance in the healthcare system in Alberta, Canada, and internationally. Choosing Wisely® is an initiative of the ABIM Foundation…
PDF of a PowerPoint presentation by Dr. Louis Hugo Francescutti, President, Canadian Medical Association.
Disclaimer: please be aware that some of these images may be considered very disturbing or graphic to some viewers.
IHE Innovation Forum X – Choosing Wisely® in Health Care: A Canadian Perspective
PDF of a PowerPoint presentation by Dr. Sam Shortt, Canadian Medical Association.
IHE Innovation Forum X – Choosing Wisely® in Health Care: A Canadian Perspective
PDF of a PowerPoint presentation by Dr. Richard Lewanczuk, Alberta Health Services.
IHE Innovation Forum X – Choosing Wisely® in Health Care: A Canadian Perspective
PDF of a PowerPoint presentation by Dr. Tom Feasby, University of Calgary.
IHE Innovation Forum X – Choosing Wisely® in Health Care: A Canadian Perspective
PDF of a PowerPoint presentation by Dr. Bill Hnydyk, Alberta Medical Association.
IHE Innovation Forum X – Choosing Wisely® in Health Care: A Canadian Perspective
PDF of a PowerPoint presentation by Ms. Cathy Pryce, Alberta Health Services.
IHE Innovation Forum X – Choosing Wisely® in Health Care: A Canadian Perspective
Choosing Wisely® in Health Care: A Canadian Perspective is the tenth IHE Innovation Forum, a semi-annual event bringing together senior public- and private-sector decision-makers to address policy issues of importance in the healthcare system in Alberta, Canada, and internationally. Choosing Wisely® is an initiative of the ABIM Foundation to improve health care in the United…
| Christa Harstall, Paul Taenzer, Nancy Zuck, Donna Angus, Carmen Moga, Ann Scott
Rationale, Aims, and Objectives: The Alberta Ambassador Program (AAP) adapted seven clinical practice guidelines on low back pain (LBP) into a single guideline spanning the continuum of care from prevention and diagnosis through to treatment. The Ambassador adaptation process was evaluated to 1 Identify the major challenges encountered and successful strategies utilized;…
This report is an analysis of the theoretical basis for value-based pricing, relevant international developments, and areas for improvement within Canada’s current patented drug pricing system. This report intends to inform future policy research, advice, and Canadian drug policy discussions regarding the feasibility and implementation of value-based pricing approaches.
INTRODUCTION: Varicella vaccine was introduced to the infant immunization schedule in each province or territory between 2000 and 2007 as a result of the Canadian ImmunizationStrategy. The impact of vaccinating children against this disease is potentially far reaching, asimmunization may also benefit those segments of the population not immunized. The objective of this paper…
PDF of a PowerPoint presentation by Mr. Deepa Singal, Mrs. Teresa Brown, and Mr. Albert Chudley.
First International Conference on the Prevention of FASD
PDF of a PowerPoint presentation by Dr. Malcolm King, SFU Faculty of Health Sciences; CIHR Institute of Aboriginal Peoples’ Health.
First International Conference on the Prevention of FASD
PDF of a PowerPoint presentation by Dr. Akinori Hisashige, Institute of Healthcare Technology Assessment, Japan.
First International Conference on the Prevention of FASD
PDF of a PowerPoint presentation by Dr. Joanne Weinberg, Professor and Distinguished University Scholar, University of British Columbia.
First International Conference on the Prevention of FASD
23 – 25 September 2013 Edmonton, Alberta IHE hosted the First International Conference on Prevention of FASD, September 23 - 25, 2013 in Edmonton, Alberta. More than 800 people were in attendance, including global experts and leaders in the health system, government, and the academic and business communities. Download the International Charter on the Prevention of FASD Well-known…
Plenary Speakers | Scientific Committee | Steering Subcommittee | Prevention Subcommittee | Organizing Committee Plenary Speakers Keynote Speaker Honorable Alison M. Redford, Q.C., Premier of Alberta, Canada Speakers Susan Astley, PhD, Research Affiliate at the Center on Human Development and Disability, University of Washington Ilona Autti-Rämö,…
Mon 23 Sep 2013 | Tue 24 Sep 2013 | Wed 25 Sep 2013 First International Conference on Prevention of FASD - Final Program Monday, 23 September 2013 8:00 – 12:30 OPENING OF THE CONFERENCE Welcome from the Steering Committee of Alberta Initiatives on FASDEgon Jonsson and Marguerite Trussler http://vimeo.com/channels/907053/77103171 FASD Prevention in a Policy…
Mon 23 Sep 2013 | Tue 24 Sep 2013 | Wed 25 Sep 2013| Other Presentations First International Conference on Prevention of FASD - Final Program Monday, 23 September 2013 13:30 – 15:00 PANEL A PRESENTATIONS Prevention of FASD in WA State: Evidence of Success (1973-2013) Dr. Susan Astley Download presentation (7.7 MB) Evaluating FASD Prevention…
Download the International Charter on the Prevention of FASD The International Charter on Prevention of FASD has been published in The Lancet Global Health, one of the world’s most influential public-health journals. The Charter – also known as the “Edmonton Charter” – was endorsed at the First International Conference on Prevention of FASD in September…
This consensus statement on Legal Issues of Fetal Alcohol Spectrum Disorder (FASD) is the product of a unique IHE Consensus Development Conference held in September 2013. The event was a three-day juried hearing of evidence and scientific findings that allowed for the engagement and collaboration of citizens and decision makers in government and the justice system in addressing…
IHE hosted the First International Conference on Prevention of FASD, September 23 - 25, 2013 in Edmonton, Alberta. More than 800 people were in attendance, including global experts and leaders in the health system, government, and the academic and business communities. Well-known speakers from around the world presented facts and findings from research, and described innovative…
PDF of a PowerPoint presentation by Mr. Jonathan Rudin, Program Director, Aboriginal Legal Services of Toronto; Chair, FASD Justice Committee.
Consensus Development Conference on Legal Issues of Fetal Alcohol Spectrum Disorder (FASD)
PDF of a PowerPoint presentation by The Honourable Judge Sheila Whelan, Provincial Court of Saskatchewan.
Consensus Development Conference on Legal Issues of Fetal Alcohol Spectrum Disorder (FASD)
PDF of a PowerPoint presentation by Ms. Donna Debolt, Social Work Consultant, Edmonton, Alberta.
Consensus Development Conference on Legal Issues of Fetal Alcohol Spectrum Disorder (FASD)
PDF of a PowerPoint presentation by Dr. Gail Andrew, Board Member, Canada FASD Research Network; Medical Site Lead, Pediatrics; Medical Director, FASD Clinical Services; Pediatric Consultant, Glenrose Rehabilitation Hospital.
Consensus Development Conference on Legal Issues of Fetal Alcohol Spectrum Disorder (FASD)
PDF of a PowerPoint presentation by Dr. Stephen Greenspan, Emeritus Professor of Educational Psychology, University of Connecticut; Clinical Professor of Psychiatry, University of Colorado.
Consensus Development Conference on Legal Issues of Fetal Alcohol Spectrum Disorder (FASD)
PDF of a PowerPoint presentation by Dr. Arlin Pachet, Clinical Neuropsychologist, Adjunct Assistant Professor, Department of Psychology, University of Calgary.
Consensus Development Conference on Legal Issues of Fetal Alcohol Spectrum Disorder (FASD)
Speakers | Jury | Steering Committee | Legal Subcommittee | Legal Working Group | Youth Ambassadors for FASD Working Group | Organizing Committee Planning for the Legal Issues Conference was carried out by a Subcommittee co-chaired by Kurt Sandstrom, Assistant Deputy Minister, Legal Services, Alberta Justice and Solicitor General; and Karen…
Program Consensus Development Conference on Legal Issues of Fetal Alcohol Spectrum Disorder (FASD) – Final Program Download Program Consensus Statement Consensus Statement on Legal Issues of Fetal Alcohol Spectrum Disorder (FASD) 2013Download Consensus Statement Media Release 20 September 2013 – FASD Jury calls for changes to legal systemDownload Media Release Conference…
Reflections from the Conference Jury Chair: The Honourable Ian Binnie, C.C., Q.C, Former Justice of the Supreme Court of Canada What was the jury experience like at the FASD Conference?http://player.vimeo.com/video/80933845 What are you taking away from this conference?http://player.vimeo.com/video/80933844 Myles Himmelreich, Motivational Speaker What supports have helped you with…
How do you engage citizens, decision-makers, and experts in an appropriate way to address complex health issues? One approach is the Consensus Development Conference. The Consensus Development Conference approach has been used effectively in Alberta by the Institute of Health Economics. The program is modelled on the National Institute of Health (NIH) Consensus Development program…
Wed 18 Sep 2013 | Thu 19 Sep 2013 | Fri 20 Sep 2013 Legal Issues of Fetal Alcohol Spectrum Disorder (FASD) – Final Program Wednesday, 18 September 2013 8:45 – 10:25 QUESTION 1: What are the implications of FASD for the legal system?a) An overview of FASD and its general implications An Introduction to FASDSterling Clarren, CEO and Scientific Director, Canada Northwest…
18 – 20 September 2013 Edmonton, Alberta Alcohol can hurt the brain and body of an unborn baby and cause Fetal Alcohol Spectrum Disorder (FASD), a serious lifelong condition that impacts both the individual and their family. A child with FASD becomes an adult with FASD, facing birth defects, developmental and learning delays and social, educational, and employment challenges. Download…
PDF of a PowerPoint presentation by Ms. Patricia MacPherson, Senior Research Manager, Correctional Service of Canada.
Consensus Development Conference on Legal Issues of Fetal Alcohol Spectrum Disorder (FASD)
Alcohol can hurt the brain and body of an unborn baby and cause Fetal Alcohol Spectrum Disorder (FASD), a serious lifelong condition that impacts both the individual and their family. A child with FASD becomes an adult with FASD, facing birth defects, developmental and learning delays and social, educational, and employment challenges.
PDF of a PowerPoint presentation by Dr. Sterling Clarren, CEO and Scientific Director, Canada Northwest FASD Research Network; Clinical Professor of Pediatrics; Faculty of Medicine, University of British Columbia; Clinical Professor of Pediatrics, School of Medicine, University of Washington. Consensus Development Conference on Legal Issues of Fetal Alcohol Spectrum…
PDF of a PowerPoint presentation by Dr. Kathy Sulik, Professor of Cell Biology and Physiology; Member of the Bowles Center for Alcohol Studies, University of North Carolina, Chapel Hill, NC, USA.
Consensus Development Conference on Legal Issues of Fetal Alcohol Spectrum Disorder (FASD)
PDF of a PowerPoint presentation by Dr. Philip Jacobs, Professor of Health Economics, Faculty of Medicine, University of Alberta; Director of Research Collaborations, IHE.
Consensus Development Conference on Legal Issues of Fetal Alcohol Spectrum Disorder (FASD)
PDF of a PowerPoint presentation by Ms. Fia Jampolsky, Chair, Yukon Human Rights Commission; Lawyer, Cabott and Cabott, Whitehorse.
Consensus Development Conference on Legal Issues of Fetal Alcohol Spectrum Disorder (FASD)
PDF of a PowerPoint presentation by Dr. Larry Burd, Professor, Department of Pediatrics, University of North Dakota School of Medicine; Director of the North Dakota Fetal Alcohol Syndrome Center and PAS Clinic.
Consensus Development Conference on Legal Issues of Fetal Alcohol Spectrum Disorder (FASD)
PDF of a PowerPoint presentation by Dr. Ab Chudley, Professor, Department of Pediatrics, University of Manitoba; Medical Director, Winnipeg Regional Health Authority Program in Genetics and Metabolism.
Consensus Development Conference on Legal Issues of Fetal Alcohol Spectrum Disorder (FASD)
PDF of a PowerPoint presentation by Dr. Jacqueline Pei, Assistant Professor, Department of Educational Psychology; Assistant Clinical Professor, Department of Pediatrics, University of Alberta.
Consensus Development Conference on Legal Issues of Fetal Alcohol Spectrum Disorder (FASD)
PDF of a PowerPoint presentation by Mr. William Edwards, Deputy Public Defender, Los Angeles County Public Defender's Office.
Consensus Development Conference on Legal Issues of Fetal Alcohol Spectrum Disorder (FASD)
PDF of a PowerPoint presentation by Dr. Allan Manson, Professor, Faculty of Law, Queen's University, Kingston, Ontario.
Consensus Development Conference on Legal Issues of Fetal Alcohol Spectrum Disorder (FASD)
| Angus Thompson, Philip Jacobs, Jessica Moffatt, Arianna Waye
This service and evaluation project originated from the Alberta courts via the collaboration of two Alberta Ministries; (1) Alberta Justice & Soliciter General and (2) Alberta Environment and Sustainable Resource Development. The impetus arose when a judge in an environmental protection case observed a need for additional attention to the mental health of workers. An Alberta…
This background document outlines the methods used to develop the Alberta Clinical Practice Guideline (CPG) for Management of Primary Headache in Adults, which was produced as part of the Alberta Ambassador Guideline Adaptation Program.
Link to Alberta Ambassador Guideline Adaptation Program
| Thanh Nguyen, Jessica Moffatt, Philip Jacobs, Anderson Chuck, Egon Jonsson
Objectives: To estimate the break-even effectiveness of the Alberta Fetal Alcohol Spectrum Disorder (FASD) Service Networks in reducing occurrences of secondary disabilities associated with FASD.
Speaker Biographies Keynote Speaker Professor Sir Albert Aynsley-Green Kt.Children's Commissioner for England, 2005-2010 Sir Al Aynsley-Green is one of the world's leading authorities on children's services, child health and childhood. Through his distinguished early career as a pediatric endocrinologist and clinical researcher, he developed a deep interest in the circumstances…
9 May 2013Edmonton, Alberta Introductory Remarks Ms. Robyn Blackadar, President and CEO, Alberta Centre for Child, Family & Community Researchhttp://vimeo.com/channels/907291/66438458 Keynote Presentation Professor Sir Albert Aynsley-Green Kt. Children's Commissioner for England, 2005-2010http://vimeo.com/channels/907291/66486081 Response Dr. April Elliott, Chief…
9 May 2013 Edmonton, Alberta Early Childhood Development: Advancing Children’s Health is the ninth IHE Innovation Forum, a semi-annual event bringing together senior public- and private-sector decision-makers to address policy issues of importance in the healthcare system in Alberta, Canada, and internationally. Key Forum Documents Innovation Forum IX – Early childhood…
Early Childhood Development: Advancing Children’s Health is the ninth IHE Innovation Forum, a semi-annual event bringing together senior public- and private-sector decision-makers to address policy issues of importance in the healthcare system in Alberta, Canada, and internationally.
Early Childhood Development: Advancing Children’s Health is the ninth IHE Innovation Forum, a semi-annual event bringing together senior public- and private-sector decision-makers to address policy issues of importance in the healthcare system in Alberta, Canada, and internationally.
Abstract: Medical wait time is a top health policy issue in Canada. Reliable data on the referral wait time from primary to specialty care are limited. Existing data on referral wait times are generally self-reported by specialists. In 2008, the Edmonton North Primary Care Network (PCN) developed a Centralized Referral Program, including a specialist database that contains…
5 May 2013 St. John's, Newfoundland The Provincial Industry Payer Agreements in an Era of National Purchasing Strategies Roundtable was a follow-up to a 2011 National Roundtable Discussion on Innovative Approaches to Industry-Payer Agreements held in Vancouver, British Columbia in association with the Canadian Agency for Drugs and Technologies in Health (CADTH) Annual Symposium.…
Biographies Hon. Fred Horne Minister of Health, Government of Alberta Mr. Horne was elected to his second term as a Member of the Legislative Assembly for Edmonton-Rutherford on April 23, 2012. On May 8, 2012, Mr. Horne was appointed as Minister of Health. He had served as Minister of Health and Wellness since October 2011. He also served as a member of the Cabinet Policy Committee…
Sunday, 5 May 2013 St. John's, Newfoundland Opening Remarks Anderson Chuck, Director of Economic Evaluation and Analytics, Institute of Health Economics Greetings from the IHE Board Mark Findlay, AstraZeneca, IHE Board Member Greetings from the Minister Honourable Fred Horne, Minister of Health, Alberta Outline of the Day Chris Henshall, Chair, HTAi Policy Forum Discussions on…
Roundtable Final Report Provincial Industry-Payer Agreements in an Era of National Pricing Strategies – National Roundtable Download Roundtable Final Report Program Provincial Industry Payer Agreements in an Era of National Purchasing Strategies – Program Download Program Background Document Industry-Payer Agreements for Pharmaceuticals: Backgrounder Download…
The Provincial Industry Payer Agreements in an Era of National Purchasing Strategies half-day invitational roundtable was part of the IHE's ongoing Methodology Forum series supported by the Institute of Health Economics, the Alberta government, and industry partners, AstraZeneca, Merck, and Eli Lilly. The event brought together academic experts, industry leaders and senior decision…
PDF of a PowerPoint presentation by Mr. Eddy Nason, Senior Researcher, Institute of Governance.
Provincial Industry Payer Agreements in an Era of National Purchasing Strategies Roundtable.
PDF of a PowerPoint presentation by Dr. Michael Drummond, Professor of Health Economics, University of York, UK.
Provincial Industry Payer Agreements in an Era of National Purchasing Strategies Roundtable.
PDF of a PowerPoint presentation by Diane McArthur, Assistant Deputy Minister, Ontario Ministry of Health and Long Term Care.
Provincial Industry Payer Agreements in an Era of National Purchasing Strategies Roundtable.
The Provincial Industry Payer Agreements in an Era of National Purchasing Strategies half-day invitational roundtable was part of the IHE's ongoing Methodology Forum series supported by the Institute of Health Economics, the Alberta government, and industry partners, AstraZeneca, Merck, and Eli Lilly. The event brought together academic experts, industry leaders and senior decision…
The Provincial Industry Payer Agreements in an Era of National Purchasing Strategies half-day invitational roundtable was part of the IHE's ongoing Methodology Forum series supported by the Institute of Health Economics, the Alberta government, and industry partners, AstraZeneca, Merck, and Eli Lilly. The event brought together academic experts, industry leaders and senior decision…
This health technology assessment report has been produced in response to a request from Alberta Health (AH) as part of the Alberta Health Technologies Decision Process (AHTDP) to perform an evaluation of the scientific evidence on the safety and effectiveness of TMJ Concepts® and Biomet® Microfixation TMJ prostheses for adults who are indicated for total TMJ replacement.…
Transcutaneous Bilirubinometry for the Screening of Hyperbilirubinemia in Neonates ≥35 Weeks’ Gestation This report was prepared for Alberta Health Services (AHS) and focuses on the published evidence about the safety, test accuracy, and clinical impact of the use of transcutaneous bilirubin (TcB) test for the screening of significant hyperbilirubinemia in term or late…
The review summarizes the current evidence on the safety, efficacy, effectiveness, and potential cost-effectiveness on the use of the BridgePoint Medical System (consisting of the CrossBoss™ catheter, Stingray™ catheter, and Stingray™ guidewire) for the recanalization of refractory coronary chronic total occlusions (CTOs). The report also describes the relevant…
| Thanh Nguyen, Egon Jonsson, Jessica Moffatt, Liz Dennett
From the Introduction: In this paper, we report a discussion of available evidence regarding the association between poverty and FASD, and regarding the economic consequences of FASD on individuals and families which may materialize an FASD - poverty trap.
19 February 2013 Edmonton, Alberta The Institute of Health Economics, in partnership with Alberta Enterprise and Advanced Education, Alberta Health, and Eli Lilly Canada, conducted a roundtable to examine the concept of Alberta Health as a Living Laboratory. The ‘Living Laboratory' concept builds off the recognition of the unique assets and opportunity we have in Alberta, including…
Biographies Dr. Lorne Tyrrell Board Chair, Institute of Health Economics Dr. Tyrrell is a former Dean of Medicine and Dentistry at the University of Alberta. He is a co-discoverer of the first oral antiviral drug to treat Hepatitis B. He is the CIHR/GlaxoSmithKline Chair in Virology at the U of A, Chair of the Gairdner Foundation, and a member of the Research Council of the Canadian…
Tuesday, 19 February 2013 Edmonton, Alberta Welcome Dr. Lorne Tyrrell, Chair, Institute of Health Economicshttp://player.vimeo.com/video/60518479 Dr. Michael McGinnis, Executive Director, Roundtable on Value & Science-Driven Health Care, United States Institute of Medicine (IOM)Download Presentation http://player.vimeo.com/video/60607075 Greetings from the Government of…
The Institute of Health Economics, in partnership with Alberta Enterprise and Advanced Education, Alberta Health, and Eli Lilly Canada, conducted a roundtable to examine the concept of Alberta Health as a Living Laboratory. The ‘Living Laboratory’ concept builds off the recognition of the unique assets and opportunity we have in Alberta, including a single health authority…
PDF of a PowerPoint presentation by Dr. Michael McGinnis, Executive Director, Roundtable on Value & Science-Driven Health Care, United States Institute of Medicine (IOM).
A "Living Laboratory" in Alberta Roundtable.
PDF of a PowerPoint presentation by Dr. Chris Henshall, Board Member, Alberta Research and Innovation Authority.
A "Living Laboratory" in Alberta Roundtable.
PDF of a PowerPoint presentation by Dr. Marvin Fritzler, Chair, Alberta Research and Innovation Authority.
A "Living Laboratory" in Alberta Roundtable.
Alberta STE Report written under contract with the Alberta Health Technologies Decision Process (AHTDP). This report is an update of the 2008 report on islet transplantation (IT) for Type 1 diabetes (T1DM). Section One of this analysis was intended to describe the profile of T1DM (definition, progression, epidemiology, and population dynamics of affected adults in Alberta, in Canada,…
| Ian Colman, Yasmin Garad, Yiye Zeng, Kiyuri Naicker, Murray Weeks, Scott Patten, Peter Jones, Angus Thompson, T. Cameron Wild
Purpose: Studies suggest that childhood trauma is linked to both depression and heavy drinking in adulthood, and may create a lifelong vulnerability to stress. Few studies have explored the effects of stress sensitization on the development of depression or heavy drinking among those who have experienced traumatic childhood events. This study aimed to determine the effect…
| Sue Ludwig, Patricia Leggett Tait, Christa Harstall
Alberta Heritage Foundation for Medical Research (AHFMR) HTA Report #22. This review was requested to determine whether conductive education as a learning approach or therapeutic intervention is safe and efficacious for children with disabilities such as cerebral palsy that impact neuromotor functioning. The review also addresses the profile of the child who would benefit from…
Alberta Heritage Foundation for Medical Research (AHFMR) HTA Report #21. The three objectives of this assessment are to determine the available scientific evidence on: the effective time interval for mammography screening in asymptomatic women aged 50 to 69 years; the effective screening interval in asymptomatic women between the ages of 40 and 49 years; and the mortality rate…
Alberta Heritage Foundation for Medical Research (AHFMR) HTA Report #18. This report has been prepared following interest by the Alberta Cord Blood Bank in obtaining advice on the comparative effectiveness and costs of different types of stem cell transplantation. Earlier assessments by the Foundation have considered peripheral blood stem cell transplantation and cord blood transplantation.…
| Maureen Yunkap Kwankam, David Hailey, Philip Jacobs
Alberta Heritage Foundation for Medical Research (AHFMR) HTA Report #13. This assessment has been prepared in view of the interest at the University of Alberta Hospital in developing a cord blood banking facility in the province and to provide information to decision makers on the current status of cord blood transplantation (CBT). The principal purpose of the assessment was to…
Alberta Heritage Foundation for Medical Research (AHFMR) HTA Report #12. This report has been prepared following a request from the provincial Clinical Practice Guidelines Program for information on the accuracy of diagnostic tests for the detection of bacterial vaginosis (BV), vulvovaginal candidiasis (VVC) and trichomoniasis in females of reproductive age. The intention of this…
Alberta Heritage Foundation for Medical Research (AHFMR) HTA Report #11. This report has been prepared in view of the increasing interest in ultrasound technology for diagnosis of osteoporosis. Until recently, quantitative ultrasound (QUS) was mainly being used in research settings. This procedure is still not covered by provincial fee schedules. The recent FDA pre-marketing approvals…
Alberta Heritage Foundation for Medical Research (AHFMR) HTA Report #10. This report has been prepared as part of a project to assess the role of high cost functional diagnostic imaging (FDI) and related methods in routine health care. In the present paper, the potential application of four FDI methods to the management of epilepsy is considered. The assessment considered the current…
Alberta Heritage Foundation for Medical Research (AHFMR) HTA Report #8. This report has been prepared to provide information to health authorities and others on the available evidence on effectiveness of HBOT and the possible economic impact on health care should a second HBO facility be established in the province. Issues addressed in the report include: Whether HBOT has been…
Alberta Heritage Foundation for Medical Research (AHFMR) HTA Report #9. The present report has been prepared following a request by Alberta Health in relation to referral of patients outside the province for treatment with stereotactic radiosurgery (SRS). There was interest by the department in the comparative effectiveness of the two main approaches to SRS (GK and LINAC) and in…
Alberta Heritage Foundation for Medical Research (AHFMR) HTA Report #7. This assessment was undertaken at the request of a Regional Health Authority to provide input into a funding decision on a computerized dynamic posturography (CDP) system for use by a rehabilitation department. The focus of this study was restricted to the clinical use of CDP by the rehabilitation community.…